(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1347615 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of INSIG1 mRNA CTD PMID:22079256 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of INSIG1 mRNA CTD PMID:26776438 (S)-nicotine increases expression ISO RGD:1347615 6480464 Nicotine results in increased expression of INSIG1 mRNA CTD PMID:23416264 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine increases expression EXP 6480464 chlorcyclizine results in increased expression of INSIG1 mRNA CTD PMID:21058326 1-benzylpiperazine increases expression EXP 6480464 N-benzylpiperazine results in increased expression of INSIG1 mRNA CTD PMID:26821219 1-naphthyl isothiocyanate multiple interactions ISO RGD:1347615 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of INSIG1 mRNA CTD PMID:27344345 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of INSIG1 mRNA CTD PMID:30723492 17alpha-ethynylestradiol multiple interactions ISO RGD:1332305 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of INSIG1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of INSIG1 mRNA CTD PMID:20170705 , PMID:26865667 17alpha-ethynylestradiol affects expression ISO RGD:1347615 6480464 Ethinyl Estradiol affects the expression of INSIG1 mRNA CTD PMID:20170705 , PMID:26865667 17alpha-ethynylestradiol increases expression ISO RGD:1347615 6480464 Ethinyl Estradiol results in increased expression of INSIG1 mRNA CTD PMID:18936297 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of INSIG1 mRNA CTD PMID:15901920 , PMID:17108234 17beta-estradiol affects expression ISO RGD:1347615 6480464 Estradiol affects the expression of INSIG1 mRNA CTD PMID:21826169 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of INSIG1 mRNA CTD PMID:32145629 17beta-estradiol decreases expression ISO RGD:1332305 6480464 Estradiol results in decreased expression of INSIG1 mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO RGD:1347615 6480464 Estradiol results in increased expression of INSIG1 mRNA CTD PMID:19167446 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO RGD:1347615 6480464 Metribolone results in increased expression of INSIG1 mRNA, Metribolone results in increased expression of INSIG1 protein CTD PMID:16751804 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1347615 6480464 Dihydrotestosterone results in increased expression of INSIG1 mRNA CTD PMID:29581250 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1332305 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1332305 6480464 2 more ... CTD PMID:30294300 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1347615 6480464 2 more ... CTD PMID:31173147 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1332305 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1347615 6480464 Tetrachlorodibenzodioxin results in increased expression of INSIG1 mRNA CTD PMID:12377990 , PMID:16704738 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of INSIG1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of INSIG1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1332305 6480464 Tetrachlorodibenzodioxin affects the expression of INSIG1 mRNA CTD PMID:21570461 , PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of INSIG1 mRNA CTD PMID:20558275 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1347615 6480464 Tetrachlorodibenzodioxin results in decreased expression of INSIG1 mRNA CTD PMID:21998131 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1332305 6480464 Tetrachlorodibenzodioxin results in increased expression of INSIG1 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1332305 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:17942748 , PMID:28433925 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of INSIG1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of INSIG1 mRNA CTD PMID:21346803 2-butoxyethanol increases expression ISO RGD:1332305 6480464 n-butoxyethanol results in increased expression of INSIG1 mRNA CTD PMID:19812364 2-hydroxypropanoic acid increases expression ISO RGD:1347615 6480464 Lactic Acid results in increased expression of INSIG1 mRNA CTD PMID:30851411 2-methylcholine affects expression ISO RGD:1347615 6480464 beta-methylcholine affects the expression of INSIG1 mRNA CTD PMID:21179406 25-hydroxycholesterol decreases expression ISO RGD:1332305 6480464 25-hydroxycholesterol results in decreased expression of INSIG1 mRNA CTD PMID:19260826 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1347615 6480464 3 more ... CTD PMID:23146750 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1332305 6480464 3 more ... CTD PMID:29216392 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of INSIG1 mRNA CTD PMID:15953391 3-phenylprop-2-enal decreases expression ISO RGD:1347615 6480464 cinnamaldehyde results in decreased expression of INSIG1 mRNA CTD PMID:17178418 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of INSIG1 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol decreases expression ISO RGD:1332305 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of INSIG1 mRNA CTD PMID:33297965 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of INSIG1 mRNA CTD PMID:36041667 5-aza-2'-deoxycytidine decreases expression ISO RGD:1347615 6480464 Decitabine results in decreased expression of INSIG1 mRNA CTD PMID:19194470 5-fluorouracil increases expression ISO RGD:1347615 6480464 Fluorouracil results in increased expression of INSIG1 mRNA CTD PMID:17039268 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of INSIG1 mRNA CTD PMID:24780913 , PMID:25825206 7,12-dimethyltetraphene affects expression ISO RGD:1332305 6480464 9 more ... CTD PMID:21785161 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:12376462 8-Br-cAMP increases expression ISO RGD:1347615 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of INSIG1 mRNA CTD PMID:22079614 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of INSIG1 mRNA CTD PMID:31881176 acetylsalicylic acid increases expression ISO RGD:1347615 6480464 Aspirin results in increased expression of INSIG1 mRNA CTD PMID:15928584 acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of INSIG1 mRNA CTD PMID:12800193 acrylamide decreases expression ISO RGD:1347615 6480464 Acrylamide results in decreased expression of INSIG1 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:1347615 6480464 Aflatoxin B1 affects the expression of INSIG1 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of INSIG1 mRNA CTD PMID:33354967 aflatoxin B1 decreases expression ISO RGD:1347615 6480464 Aflatoxin B1 results in decreased expression of INSIG1 mRNA CTD PMID:27153756 , PMID:32234424 aflatoxin B1 decreases methylation ISO RGD:1347615 6480464 Aflatoxin B1 results in decreased methylation of INSIG1 gene CTD PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of INSIG1 mRNA CTD PMID:23630614 aflatoxin B1 decreases expression ISO RGD:1332305 6480464 Aflatoxin B1 results in decreased expression of INSIG1 mRNA CTD PMID:19770486 all-trans-retinoic acid multiple interactions ISO RGD:1347615 6480464 [Tretinoin co-treated with arsenic trioxide] results in decreased expression of INSIG1 mRNA CTD PMID:15894607 all-trans-retinoic acid increases expression ISO RGD:1347615 6480464 Tretinoin results in increased expression of INSIG1 mRNA CTD PMID:33167477 all-trans-retinoic acid decreases expression ISO RGD:1347615 6480464 Tretinoin results in decreased expression of INSIG1 mRNA CTD PMID:15894607 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of INSIG1 mRNA CTD PMID:16483693 amphotericin B increases expression ISO RGD:1347615 6480464 Amphotericin B analog results in increased expression of INSIG1 mRNA, Amphotericin B results in increased expression of INSIG1 mRNA CTD PMID:28534445 antimycin A increases expression ISO RGD:1347615 6480464 Antimycin A results in increased expression of INSIG1 mRNA CTD PMID:33512557 Archazolid B increases expression ISO RGD:1347615 6480464 archazolid B results in increased expression of INSIG1 mRNA CTD PMID:25218289 aristolochic acid A decreases expression ISO RGD:1347615 6480464 aristolochic acid I results in decreased expression of INSIG1 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:1332305 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of INSIG1 mRNA CTD PMID:23650126 arsenous acid decreases expression ISO RGD:1347615 6480464 Arsenic Trioxide results in decreased expression of INSIG1 mRNA CTD PMID:15894607 arsenous acid multiple interactions ISO RGD:1347615 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of INSIG1 mRNA CTD PMID:15894607 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of INSIG1 mRNA CTD PMID:36841081 avobenzone increases expression ISO RGD:1347615 6480464 avobenzone results in increased expression of INSIG1 mRNA CTD PMID:31016361 azoxystrobin affects expression ISO RGD:1347615 6480464 azoxystrobin affects the expression of INSIG1 mRNA CTD PMID:33512557 beauvericin increases expression ISO RGD:1347615 6480464 beauvericin results in increased expression of INSIG1 mRNA CTD PMID:29203277 benzalkonium chloride increases expression ISO RGD:1332305 6480464 Benzalkonium Compounds results in increased expression of INSIG1 mRNA CTD PMID:31199489 benzene affects expression EXP 6480464 Benzene affects the expression of INSIG1 mRNA CTD PMID:15878777 benzo[a]pyrene increases expression ISO RGD:1332305 6480464 Benzo(a)pyrene results in increased expression of INSIG1 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:1347615 6480464 Benzo(a)pyrene results in decreased expression of INSIG1 mRNA CTD PMID:32234424 benzo[a]pyrene affects expression ISO RGD:1332305 6480464 Benzo(a)pyrene affects the expression of INSIG1 mRNA CTD PMID:22342234 benzo[a]pyrene multiple interactions ISO RGD:1332305 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of INSIG1 mRNA] CTD PMID:22228805 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1347615 6480464 7 more ... CTD PMID:20382639 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of INSIG1 mRNA CTD PMID:16648578 bezafibrate increases expression ISO RGD:1332305 6480464 Bezafibrate results in increased expression of INSIG1 mRNA CTD PMID:17118139 , PMID:19124612 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of INSIG1 mRNA CTD PMID:15728792 , PMID:33983380 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1332305 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A affects expression ISO RGD:1332305 6480464 bisphenol A affects the expression of INSIG1 mRNA CTD PMID:21932408 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of INSIG1 mRNA CTD PMID:36041667 bisphenol A decreases methylation ISO RGD:1347615 6480464 bisphenol A results in decreased methylation of INSIG1 promoter CTD PMID:30352284 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of INSIG1 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1332305 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of INSIG1 mRNA CTD PMID:30816183 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of INSIG1 mRNA CTD PMID:12075121 more ... bisphenol A increases expression ISO RGD:1347615 6480464 bisphenol A results in increased expression of INSIG1 mRNA CTD PMID:25047013 , PMID:29275510 bisphenol A affects expression ISO RGD:1347615 6480464 bisphenol A affects the expression of INSIG1 mRNA CTD PMID:20170705 , PMID:21826169 bisphenol A increases expression ISO RGD:1332305 6480464 bisphenol A results in increased expression of INSIG1 mRNA CTD PMID:21932408 , PMID:25270620 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of INSIG1 mRNA CTD PMID:36041667 bleomycin A2 multiple interactions ISO RGD:1332305 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of INSIG1 mRNA], lenabasum inhibits the reaction [Bleomycin results in decreased expression of INSIG1 mRNA] CTD PMID:30825431 bleomycin A2 decreases expression ISO RGD:1332305 6480464 Bleomycin results in decreased expression of INSIG1 mRNA CTD PMID:30825431 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of INSIG1 mRNA CTD PMID:32479839 butan-1-ol multiple interactions ISO RGD:1347615 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of INSIG1 mRNA CTD PMID:29432896 Butylbenzyl phthalate decreases expression EXP 6480464 butylbenzyl phthalate results in decreased expression of INSIG1 mRNA CTD PMID:15728792 butyric acid increases expression EXP 6480464 Butyric Acid results in increased expression of INSIG1 mRNA CTD PMID:12800193 butyric acid increases expression ISO RGD:1347615 6480464 Butyric Acid results in increased expression of INSIG1 mRNA CTD PMID:34581912 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of INSIG1 mRNA CTD PMID:19010381 cadmium dichloride increases expression ISO RGD:1347615 6480464 Cadmium Chloride results in increased expression of INSIG1 mRNA CTD PMID:25596134 cadmium sulfate multiple interactions ISO RGD:1347615 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of INSIG1 mRNA CTD PMID:18654764 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of INSIG1 mRNA CTD PMID:20864626 , PMID:25868845 calcitriol multiple interactions ISO RGD:1347615 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of INSIG1 mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:1347615 6480464 Calcitriol results in increased expression of INSIG1 mRNA CTD PMID:21592394 cannabidiol multiple interactions ISO RGD:1332305 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of INSIG1 mRNA] CTD PMID:30825431 captan increases expression ISO RGD:1332305 6480464 Captan results in increased expression of INSIG1 mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:1347615 6480464 Carbamazepine affects the expression of INSIG1 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1347615 6480464 Nanotubes, Carbon results in increased expression of INSIG1 mRNA CTD PMID:24389112 carbon nanotube decreases expression ISO RGD:1332305 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carmustine decreases expression ISO RGD:1347615 6480464 Carmustine results in decreased expression of INSIG1 mRNA CTD PMID:15980968 celastrol increases expression ISO RGD:1347615 6480464 celastrol results in increased expression of INSIG1 mRNA CTD PMID:17010675 chloroacetaldehyde increases expression ISO RGD:1347615 6480464 chloroacetaldehyde results in increased expression of INSIG1 mRNA CTD PMID:25596134 chloroethene increases expression ISO RGD:1332305 6480464 Vinyl Chloride results in increased expression of INSIG1 mRNA CTD PMID:18579281 chromium(6+) decreases expression ISO RGD:1347615 6480464 chromium hexavalent ion results in decreased expression of INSIG1 mRNA CTD PMID:30690063 cidofovir anhydrous increases expression ISO RGD:1347615 6480464 Cidofovir results in increased expression of INSIG1 mRNA CTD PMID:25596134 ciguatoxin CTX1B affects expression ISO RGD:1332305 6480464 Ciguatoxins affects the expression of INSIG1 mRNA CTD PMID:18353800 cisplatin multiple interactions ISO RGD:1347615 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of INSIG1 mRNA, Cisplatin affects the reaction [Piroxicam results in decreased expression of INSIG1 mRNA] CTD PMID:21858171 , PMID:27392435 cisplatin decreases expression ISO RGD:1347615 6480464 Cisplatin results in decreased expression of INSIG1 mRNA CTD PMID:27594783 clobetasol increases expression ISO RGD:1332305 6480464 Clobetasol results in increased expression of INSIG1 mRNA CTD PMID:27462272 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of INSIG1 mRNA CTD PMID:12851107 , PMID:17126302 cobalt dichloride multiple interactions ISO RGD:1347615 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of INSIG1 mRNA CTD PMID:18654764 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of INSIG1 mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:1347615 6480464 cobaltous chloride results in increased expression of INSIG1 mRNA CTD PMID:19376846 colforsin daropate hydrochloride multiple interactions ISO RGD:1347615 6480464 AR protein promotes the reaction [Colforsin results in increased expression of INSIG1 protein] CTD PMID:16751804 colforsin daropate hydrochloride increases expression ISO RGD:1347615 6480464 Colforsin results in increased expression of INSIG1 mRNA, Colforsin results in increased expression of INSIG1 protein CTD PMID:16751804 copper atom multiple interactions ISO RGD:1347615 6480464 [Disulfiram binds to Copper] which results in decreased expression of INSIG1 mRNA, [NSC 689534 binds to Copper] which results in increased expression of INSIG1 mRNA CTD PMID:20971185 , PMID:24690739 copper atom decreases expression EXP 6480464 Copper results in decreased expression of INSIG1 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:1347615 6480464 [Disulfiram binds to Copper] which results in decreased expression of INSIG1 mRNA, [NSC 689534 binds to Copper] which results in increased expression of INSIG1 mRNA CTD PMID:20971185 , PMID:24690739 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of INSIG1 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:1347615 6480464 Copper Sulfate results in increased expression of INSIG1 mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:1347615 6480464 Coumestrol results in increased expression of INSIG1 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1347615 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 crizotinib increases expression ISO RGD:1347615 6480464 crizotinib results in increased expression of INSIG1 mRNA CTD PMID:23707608 CU-O LINKAGE increases expression ISO RGD:1347615 6480464 cupric oxide results in increased expression of INSIG1 mRNA CTD PMID:22077320 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of INSIG1 mRNA CTD PMID:27523638 cyclosporin A decreases expression ISO RGD:1347615 6480464 Cyclosporine results in decreased expression of INSIG1 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1347615 6480464 Cyclosporine results in increased expression of INSIG1 mRNA CTD PMID:25596134 more ... cyclosporin A multiple interactions ISO RGD:1347615 6480464 [Cyclosporine co-treated with Cholic Acids] affects the expression of INSIG1 mRNA CTD PMID:27344345 cylindrospermopsin decreases expression ISO RGD:1347615 6480464 cylindrospermopsin results in decreased expression of INSIG1 mRNA CTD PMID:24921660 cyproconazole increases expression ISO RGD:1332305 6480464 cyproconazole results in increased expression of INSIG1 mRNA CTD PMID:22045034 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of INSIG1 mRNA CTD PMID:23640034 desmosterol decreases expression ISO RGD:1332305 6480464 Desmosterol results in decreased expression of INSIG1 protein CTD PMID:19260826 dexamethasone decreases expression ISO RGD:1332305 6480464 Dexamethasone results in decreased expression of INSIG1 mRNA CTD PMID:22733784 Di-n-hexyl phthalate decreases expression EXP 6480464 di-n-hexyl phthalate results in decreased expression of INSIG1 mRNA CTD PMID:33983380 diarsenic trioxide multiple interactions ISO RGD:1347615 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of INSIG1 mRNA CTD PMID:15894607 diarsenic trioxide decreases expression ISO RGD:1347615 6480464 Arsenic Trioxide results in decreased expression of INSIG1 mRNA CTD PMID:15894607 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of INSIG1 mRNA CTD PMID:15728792 more ... Dicyclohexyl phthalate decreases expression EXP 6480464 dicyclohexyl phthalate results in decreased expression of INSIG1 mRNA CTD PMID:33983380 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of INSIG1 mRNA CTD PMID:37077353 diisobutyl phthalate decreases expression EXP 6480464 diisobutyl phthalate results in decreased expression of INSIG1 mRNA CTD PMID:33983380 diisononyl phthalate decreases expression EXP 6480464 diisononyl phthalate results in decreased expression of INSIG1 mRNA CTD PMID:33983380 dimethylarsinic acid multiple interactions ISO RGD:1332305 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of INSIG1 mRNA CTD PMID:34876320 dimethylselenide multiple interactions ISO RGD:1347615 6480464 [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of INSIG1-DT mRNA] which results in decreased expression of INSIG1 mRNA CTD PMID:33656867 dioxygen increases expression ISO RGD:1347615 6480464 Oxygen deficiency results in increased expression of INSIG1 mRNA CTD PMID:25596134 dipentyl phthalate decreases expression EXP 6480464 di-n-pentyl phthalate results in decreased expression of INSIG1 mRNA CTD PMID:15728792 , PMID:33983380 disulfiram multiple interactions ISO RGD:1347615 6480464 [Disulfiram binds to Copper] which results in decreased expression of INSIG1 mRNA CTD PMID:24690739 dorsomorphin multiple interactions ISO RGD:1347615 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1347615 6480464 Doxorubicin results in decreased expression of INSIG1 mRNA CTD PMID:29803840 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of INSIG1 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1347615 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INSIG1 mRNA CTD PMID:19167446 entinostat decreases expression ISO RGD:1347615 6480464 entinostat results in decreased expression of INSIG1 mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:1332305 6480464 epoxiconazole results in decreased expression of INSIG1 mRNA CTD PMID:35436446 ethanol multiple interactions EXP 6480464 [Fish Oils co-treated with Ethanol] results in increased expression of INSIG1 mRNA CTD PMID:17347304 ethanol affects expression ISO RGD:1332305 6480464 Ethanol affects the expression of INSIG1 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:1347615 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of INSIG1 mRNA CTD PMID:29432896 ethyl methanesulfonate decreases expression ISO RGD:1347615 6480464 Ethyl Methanesulfonate results in decreased expression of INSIG1 mRNA CTD PMID:23649840 etoposide affects response to substance ISO RGD:1347615 6480464 INSIG1 protein affects the susceptibility to Etoposide CTD PMID:16217747 fenofibrate decreases expression ISO RGD:1347615 6480464 Fenofibrate results in decreased expression of INSIG1 mRNA CTD PMID:25572481 fluoranthene decreases expression ISO RGD:1332305 6480464 fluoranthene results in decreased expression of INSIG1 mRNA CTD PMID:28329830 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of INSIG1 mRNA CTD PMID:21852994 flusilazole affects expression ISO RGD:1332305 6480464 flusilazole affects the expression of INSIG1 mRNA CTD PMID:21195148 , PMID:22634333 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of INSIG1 mRNA CTD PMID:24136188 folic acid increases expression ISO RGD:1347615 6480464 Folic Acid results in increased expression of INSIG1 mRNA CTD PMID:11723236 folic acid decreases expression ISO RGD:1332305 6480464 Folic Acid results in decreased expression of INSIG1 mRNA CTD PMID:25629700 formaldehyde decreases expression ISO RGD:1347615 6480464 Formaldehyde results in decreased expression of INSIG1 mRNA CTD PMID:23649840 fructose decreases expression ISO RGD:1332305 6480464 Fructose results in decreased expression of INSIG1 protein CTD PMID:22698815 fructose increases expression ISO RGD:1332305 6480464 Fructose results in increased expression of INSIG1 mRNA CTD PMID:22698815 fructose multiple interactions ISO RGD:1332305 6480464 Phenylbutyrates inhibits the reaction [Fructose results in decreased expression of INSIG1 protein] CTD PMID:22698815 furan increases expression ISO RGD:1332305 6480464 furan results in increased expression of INSIG1 mRNA CTD PMID:24183702 , PMID:24910943 Ganoderic acid A decreases expression ISO RGD:1347615 6480464 ganoderic acid A results in decreased expression of INSIG1 mRNA CTD PMID:29852127 gedunin increases expression ISO RGD:1347615 6480464 gedunin results in increased expression of INSIG1 mRNA CTD PMID:17010675 gemcitabine increases expression ISO RGD:1347615 6480464 Gemcitabine results in increased expression of INSIG1 mRNA CTD PMID:17039268 genistein increases expression ISO RGD:1347615 6480464 Genistein results in increased expression of INSIG1 mRNA CTD PMID:18847459 , PMID:26865667 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of INSIG1 mRNA CTD PMID:33387578 GW 3965 increases expression ISO RGD:1347615 6480464 GW 3965 results in increased expression of INSIG1 mRNA CTD PMID:31437187 GW 7647 increases expression ISO RGD:1347615 6480464 GW 7647 results in increased expression of INSIG1 mRNA CTD PMID:31437187 hexaconazole affects expression ISO RGD:1332305 6480464 hexaconazole affects the expression of INSIG1 mRNA CTD PMID:21195148 hydrogen peroxide multiple interactions ISO RGD:1347615 6480464 [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of INSIG1 mRNA CTD PMID:18032389 hydrogen peroxide decreases expression ISO RGD:1347615 6480464 Hydrogen Peroxide results in decreased expression of INSIG1 mRNA CTD PMID:34581912 hydroxyl multiple interactions ISO RGD:1347615 6480464 [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of INSIG1-DT mRNA] which results in decreased expression of INSIG1 mRNA CTD PMID:33656867 ibuprofen increases expression ISO RGD:1347615 6480464 Ibuprofen results in increased expression of INSIG1 mRNA CTD PMID:25596134 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of INSIG1 mRNA CTD PMID:22129741 irinotecan decreases expression ISO RGD:1347615 6480464 Irinotecan analog results in decreased expression of INSIG1 mRNA CTD PMID:18927307 isobutanol multiple interactions ISO RGD:1347615 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of INSIG1 mRNA CTD PMID:29432896 isoflavones affects expression ISO RGD:1347615 6480464 Isoflavones affects the expression of INSIG1 mRNA CTD PMID:16365062 isoflavones increases expression ISO RGD:1347615 6480464 Isoflavones results in increased expression of INSIG1 mRNA CTD PMID:17374662 isotretinoin decreases expression ISO RGD:1347615 6480464 Isotretinoin results in decreased expression of INSIG1 mRNA CTD PMID:20436886 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of INSIG1 mRNA CTD PMID:37077353 lead(II) chloride multiple interactions ISO RGD:1347615 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of INSIG1 mRNA CTD PMID:18654764 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of INSIG1 mRNA CTD PMID:24136188 linalool increases expression ISO RGD:1332305 6480464 linalool results in increased expression of INSIG1 protein CTD PMID:21944868 linalool increases expression ISO RGD:1347615 6480464 linalool results in increased expression of INSIG1 protein CTD PMID:21944868 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of INSIG1 mRNA CTD PMID:16415329 lipopolysaccharide multiple interactions ISO RGD:1347615 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of INSIG1 mRNA more ... CTD PMID:35811015 , PMID:35877022 lipopolysaccharide increases expression ISO RGD:1347615 6480464 Lipopolysaccharides results in increased expression of INSIG1 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions EXP 6480464 Ranitidine inhibits the reaction [Lipopolysaccharides results in decreased expression of INSIG1 mRNA] CTD PMID:16415329 lovastatin increases expression ISO RGD:1347615 6480464 Lovastatin results in increased expression of INSIG1 mRNA CTD PMID:19260826 lovastatin multiple interactions ISO RGD:1332305 6480464 [Dietary Fats co-treated with Lovastatin] affects the expression of INSIG1 mRNA CTD PMID:29852127 lovastatin increases expression ISO RGD:1332305 6480464 Lovastatin results in increased expression of INSIG1 mRNA CTD PMID:19260826 maneb multiple interactions ISO RGD:1332305 6480464 [Maneb co-treated with Paraquat] results in decreased expression of INSIG1 mRNA CTD PMID:36117858 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of INSIG1 mRNA CTD PMID:28801915 manganese(II) chloride increases methylation EXP 6480464 manganese chloride results in increased methylation of INSIG1 gene CTD PMID:28801915 mercury dibromide decreases expression ISO RGD:1347615 6480464 mercuric bromide results in decreased expression of INSIG1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1347615 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of INSIG1 mRNA CTD PMID:27188386 metformin increases expression ISO RGD:1332305 6480464 Metformin results in increased expression of INSIG1 mRNA CTD PMID:23457588 methyl methanesulfonate decreases expression ISO RGD:1347615 6480464 Methyl Methanesulfonate results in decreased expression of INSIG1 mRNA CTD PMID:23649840 methylarsonic acid multiple interactions ISO RGD:1332305 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of INSIG1 mRNA CTD PMID:34876320 methylmercury chloride decreases expression ISO RGD:1332305 6480464 methylmercuric chloride results in decreased expression of INSIG1 mRNA CTD PMID:19465457 methylmercury chloride decreases expression ISO RGD:1347615 6480464 methylmercuric chloride results in decreased expression of INSIG1 mRNA CTD PMID:27188386 miconazole increases expression ISO RGD:1332305 6480464 Miconazole results in increased expression of INSIG1 mRNA CTD PMID:27462272 microcystin-LR increases expression ISO RGD:1332305 6480464 cyanoginosin LR results in increased expression of INSIG1 mRNA CTD PMID:17383702 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of INSIG1 mRNA CTD PMID:22129741 N-ethyl-N-nitrosourea decreases expression EXP 6480464 Ethylnitrosourea results in decreased expression of INSIG1 mRNA CTD PMID:15954086 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of INSIG1 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of INSIG1 mRNA CTD PMID:22129741 N-nitrosomorpholine decreases expression EXP 6480464 N-nitrosomorpholine results in decreased expression of INSIG1 mRNA CTD PMID:19716841 N-Nitrosopyrrolidine decreases expression ISO RGD:1347615 6480464 N-Nitrosopyrrolidine results in decreased expression of INSIG1 mRNA CTD PMID:32234424 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 Ranitidine inhibits the reaction [Lipopolysaccharides results in decreased expression of INSIG1 mRNA] CTD PMID:16415329 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of INSIG1 mRNA CTD PMID:24136188 nickel atom increases expression ISO RGD:1347615 6480464 Nickel results in increased expression of INSIG1 mRNA CTD PMID:23195993 nickel atom decreases expression ISO RGD:1347615 6480464 Nickel results in decreased expression of INSIG1 mRNA CTD PMID:24768652 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of INSIG1 mRNA CTD PMID:26776438 nicotine increases expression ISO RGD:1347615 6480464 Nicotine results in increased expression of INSIG1 mRNA CTD PMID:23416264 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of INSIG1 mRNA CTD PMID:33484710 O-methyleugenol decreases expression ISO RGD:1347615 6480464 methyleugenol results in decreased expression of INSIG1 mRNA CTD PMID:32234424 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of INSIG1 mRNA CTD PMID:25729387 oxaliplatin decreases expression ISO RGD:1347615 6480464 oxaliplatin results in decreased expression of INSIG1 mRNA CTD PMID:16510598 p-chloromercuribenzoic acid decreases expression ISO RGD:1347615 6480464 p-Chloromercuribenzoic Acid results in decreased expression of INSIG1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1347615 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of INSIG1 mRNA CTD PMID:27188386 paclitaxel affects response to substance ISO RGD:1347615 6480464 INSIG1 protein affects the susceptibility to Paclitaxel CTD PMID:16217747 paracetamol increases expression ISO RGD:1332305 6480464 Acetaminophen results in increased expression of INSIG1 mRNA CTD PMID:17585979 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of INSIG1 mRNA CTD PMID:30723492 paracetamol decreases expression ISO RGD:1347615 6480464 Acetaminophen results in decreased expression of INSIG1 mRNA CTD PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of INSIG1 mRNA CTD PMID:22112502 , PMID:33387578 paraquat increases expression EXP 6480464 Paraquat results in increased expression of INSIG1 mRNA CTD PMID:32680482 paraquat multiple interactions ISO RGD:1332305 6480464 [Maneb co-treated with Paraquat] results in decreased expression of INSIG1 mRNA CTD PMID:36117858 perfluorononanoic acid decreases expression ISO RGD:1347615 6480464 perfluoro-n-nonanoic acid results in decreased expression of INSIG1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of INSIG1 mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1347615 6480464 perfluorooctane sulfonic acid results in decreased expression of INSIG1 mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of INSIG1 mRNA CTD PMID:19162173 perfluorooctanoic acid decreases expression ISO RGD:1332305 6480464 perfluorooctanoic acid results in decreased expression of INSIG1 protein CTD PMID:25092180 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of INSIG1 mRNA CTD PMID:31324951 phenobarbital decreases expression ISO RGD:1332305 6480464 Phenobarbital results in decreased expression of INSIG1 mRNA CTD PMID:19270015 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of INSIG1 mRNA CTD PMID:19162173 phenylmercury acetate decreases expression ISO RGD:1347615 6480464 Phenylmercuric Acetate results in decreased expression of INSIG1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1347615 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of INSIG1 mRNA CTD PMID:27188386 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of INSIG1 mRNA CTD PMID:12376462 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of INSIG1 protein CTD PMID:19248225 pirinixic acid decreases expression ISO RGD:1332305 6480464 pirinixic acid results in decreased expression of INSIG1 mRNA CTD PMID:23811191 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of INSIG1 mRNA CTD PMID:17126302 , PMID:19162173 pirinixic acid increases expression ISO RGD:1332305 6480464 pirinixic acid results in increased expression of INSIG1 mRNA CTD PMID:17118139 piroxicam multiple interactions ISO RGD:1347615 6480464 Cisplatin affects the reaction [Piroxicam results in decreased expression of INSIG1 mRNA] CTD PMID:21858171 piroxicam decreases expression ISO RGD:1347615 6480464 Piroxicam results in decreased expression of INSIG1 mRNA CTD PMID:21858171 potassium chromate multiple interactions ISO RGD:1347615 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of INSIG1 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1347615 6480464 potassium chromate(VI) results in decreased expression of INSIG1 mRNA CTD PMID:22079256 , PMID:22714537 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1332305 6480464 Pregnenolone Carbonitrile results in decreased expression of INSIG1 mRNA CTD PMID:28903501 progesterone increases expression ISO RGD:1347615 6480464 Progesterone results in increased expression of INSIG1 mRNA CTD PMID:18070364 propiconazole increases expression ISO RGD:1347615 6480464 propiconazole results in increased expression of INSIG1 mRNA CTD PMID:30989312 propiconazole multiple interactions ISO RGD:1347615 6480464 [propiconazole co-treated with tebuconazole] results in increased expression of INSIG1 mRNA CTD PMID:30989312 quercetin 3-O-beta-D-glucofuranoside multiple interactions ISO RGD:1347615 6480464 [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of INSIG1 mRNA CTD PMID:18032389 quercetin 3-O-beta-D-glucopyranoside multiple interactions ISO RGD:1347615 6480464 [isoquercitrin co-treated with Hydrogen Peroxide] results in increased expression of INSIG1 mRNA CTD PMID:18032389 rac-lactic acid increases expression ISO RGD:1347615 6480464 Lactic Acid results in increased expression of INSIG1 mRNA CTD PMID:30851411 raloxifene increases expression ISO RGD:1347615 6480464 Raloxifene Hydrochloride results in increased expression of INSIG1 mRNA CTD PMID:16497877 ranitidine multiple interactions EXP 6480464 Ranitidine inhibits the reaction [Lipopolysaccharides results in decreased expression of INSIG1 mRNA] CTD PMID:16415329 resveratrol multiple interactions ISO RGD:1347615 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of INSIG1 mRNA CTD PMID:19167446 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of INSIG1 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1347615 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of INSIG1 mRNA CTD PMID:35811015 sarin increases expression ISO RGD:1347615 6480464 Sarin results in increased expression of INSIG1 mRNA CTD PMID:19522546 sarin decreases expression ISO RGD:1347615 6480464 Sarin results in decreased expression of INSIG1 mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:1347615 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1347615 6480464 Silicon Dioxide analog results in increased expression of INSIG1 mRNA, Silicon Dioxide results in increased expression of INSIG1 mRNA CTD PMID:23806026 , PMID:25351596 sirolimus multiple interactions ISO RGD:1347615 6480464 [(+)-JQ1 compound co-treated with Sirolimus] affects the expression of INSIG1 mRNA CTD PMID:25307878 sodium arsenate multiple interactions ISO RGD:1332305 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of INSIG1 mRNA CTD PMID:34876320 sodium arsenite decreases expression ISO RGD:1347615 6480464 sodium arsenite results in decreased expression of INSIG1 mRNA CTD PMID:12679051 sodium arsenite multiple interactions ISO RGD:1332305 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of INSIG1 mRNA CTD PMID:34876320 sodium arsenite increases expression ISO RGD:1347615 6480464 sodium arsenite results in increased expression of INSIG1 mRNA CTD PMID:16966095 more ... sodium dichromate increases expression ISO RGD:1332305 6480464 sodium bichromate results in increased expression of INSIG1 mRNA CTD PMID:31558096 starch multiple interactions EXP 6480464 Starch analog inhibits the reaction [Rapeseed Oil metabolite results in decreased expression of INSIG1 mRNA] CTD PMID:27363782 streptozocin multiple interactions ISO RGD:1332305 6480464 [Dietary Fats co-treated with Streptozocin] results in increased expression of INSIG1 mRNA CTD PMID:33359794 succimer multiple interactions ISO RGD:1332305 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of INSIG1 mRNA CTD PMID:21641980 sulindac sulfide decreases expression ISO RGD:1347615 6480464 sulindac sulfide results in decreased expression of INSIG1 mRNA CTD PMID:12734198 sunitinib increases expression ISO RGD:1347615 6480464 Sunitinib results in increased expression of INSIG1 mRNA CTD PMID:31533062 T-2 toxin decreases expression ISO RGD:1347615 6480464 T-2 Toxin results in decreased expression of INSIG1 mRNA CTD PMID:34581912 tebuconazole multiple interactions ISO RGD:1347615 6480464 [propiconazole co-treated with tebuconazole] results in increased expression of INSIG1 mRNA CTD PMID:30989312 tebuconazole increases expression ISO RGD:1347615 6480464 tebuconazole results in increased expression of INSIG1 mRNA CTD PMID:30458266 , PMID:30989312 tebufenpyrad increases expression ISO RGD:1347615 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of INSIG1 mRNA CTD PMID:33512557 temozolomide decreases expression ISO RGD:1347615 6480464 Temozolomide results in decreased expression of INSIG1 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO RGD:1347615 6480464 tert-Butylhydroperoxide results in decreased expression of INSIG1 mRNA CTD PMID:15336504 testosterone multiple interactions ISO RGD:1347615 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of INSIG1 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1347615 6480464 Testosterone results in increased expression of INSIG1 mRNA CTD PMID:21592394 tetrachloroethene decreases expression ISO RGD:1347615 6480464 Tetrachloroethylene results in decreased expression of INSIG1 mRNA CTD PMID:16010555 tetrachloroethene increases expression ISO RGD:1332305 6480464 Tetrachloroethylene results in increased expression of INSIG1 mRNA CTD PMID:28973375 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of INSIG1 mRNA CTD PMID:16239168 tetrachloromethane decreases expression ISO RGD:1332305 6480464 Carbon Tetrachloride results in decreased expression of INSIG1 mRNA CTD PMID:27339419 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of INSIG1 mRNA CTD PMID:22112502 thapsigargin decreases expression ISO RGD:1347615 6480464 Thapsigargin results in decreased expression of INSIG1 mRNA CTD PMID:22378314 thapsigargin increases expression ISO RGD:1347615 6480464 Thapsigargin results in increased expression of INSIG1 mRNA CTD PMID:29453283 thimerosal decreases expression ISO RGD:1347615 6480464 Thimerosal results in decreased expression of INSIG1 mRNA CTD PMID:27188386 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of INSIG1 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1332305 6480464 titanium dioxide results in increased expression of INSIG1 mRNA CTD PMID:29264374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of INSIG1 mRNA CTD PMID:25729387 topotecan affects response to substance ISO RGD:1347615 6480464 INSIG1 protein affects the susceptibility to Topotecan CTD PMID:16217747 triadimefon affects expression ISO RGD:1332305 6480464 triadimefon affects the expression of INSIG1 mRNA CTD PMID:21195148 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of INSIG1 mRNA CTD PMID:33387578 trichostatin A affects expression ISO RGD:1347615 6480464 trichostatin A affects the expression of INSIG1 mRNA CTD PMID:28542535 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of INSIG1 mRNA CTD PMID:30589522 Triptolide decreases expression ISO RGD:1332305 6480464 triptolide results in decreased expression of INSIG1 mRNA CTD PMID:32835833 troglitazone multiple interactions EXP 6480464 [troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of INSIG1 protein CTD PMID:19248225 troglitazone decreases expression ISO RGD:1347615 6480464 troglitazone results in decreased expression of INSIG1 mRNA CTD PMID:25572481 tunicamycin decreases expression ISO RGD:1347615 6480464 Tunicamycin results in decreased expression of INSIG1 mRNA CTD PMID:22378314 , PMID:29453283 uranium atom affects expression ISO RGD:1347615 6480464 Uranium affects the expression of INSIG1 mRNA CTD PMID:15672453 valproic acid affects expression ISO RGD:1332305 6480464 Valproic Acid affects the expression of INSIG1 mRNA CTD PMID:17292431 valproic acid decreases expression ISO RGD:1347615 6480464 Valproic Acid results in decreased expression of INSIG1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1347615 6480464 Valproic Acid affects the expression of INSIG1 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1332305 6480464 Valproic Acid results in decreased expression of INSIG1 mRNA CTD PMID:22045034 valproic acid decreases methylation ISO RGD:1347615 6480464 Valproic Acid results in decreased methylation of INSIG1 gene CTD PMID:29154799 vanadium atom decreases expression ISO RGD:1347615 6480464 Vanadium results in decreased expression of INSIG1 mRNA CTD PMID:19000753 vanadium(0) decreases expression ISO RGD:1347615 6480464 Vanadium results in decreased expression of INSIG1 mRNA CTD PMID:19000753 vancomycin increases expression ISO RGD:1332305 6480464 Vancomycin results in increased expression of INSIG1 mRNA CTD PMID:18930951 vandetanib increases expression ISO RGD:1347615 6480464 vandetanib results in increased expression of INSIG1 mRNA CTD PMID:16052530 vanillin decreases expression ISO RGD:1347615 6480464 vanillin results in decreased expression of INSIG1 mRNA CTD PMID:17178418 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of INSIG1 mRNA CTD PMID:22570695 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of INSIG1 mRNA CTD PMID:23034163 vorinostat decreases expression ISO RGD:1347615 6480464 vorinostat results in decreased expression of INSIG1 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO RGD:1347615 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of INSIG1 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1347615 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of INSIG1 mRNA CTD PMID:18593933 zoledronic acid increases expression ISO RGD:1347615 6480464 zoledronic acid results in increased expression of INSIG1 mRNA CTD PMID:24714768 , PMID:25596134